What's breaking now, across thousands of outlets.
Earnings season is here, and four stocks are trading at or below where they sat before their last reports, with no sign the businesses got worse.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
Key PointsQuantumScape reported Q3 2026 financial results yesterday.
With Muse helping people shop, Meta also envisions a new revenue source beyond its ad business: taking a cut of transactions.
Societe Generale notes that the Korean Won (KRW) has risen to a fresh two-year high near 1323/USD after the Bank of Korea (BoK) unanimously kept its policy rate at 3.0% with a hawkish tone.
Moderna and Merck are expected to share the Phase 3 data for their experimental cancer vaccine this weekend at a medical conference.
Key PointsPalantir is known to underpromise and overdeliver.
Factory expansions and new sports-focused products position Vita Coco to sustain growth beyond near-term margin headwinds.
